Alpha Teknova, Inc. (TKNO) stock
TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30144% above fair value
$8.29−0.32 (-3.77%)
Close on Nov 12, 2026Market cap $445.34MP/E –Yield –
Alpha Teknova total assets
Total assets on the balance sheet at the end of each period.
Alpha Teknova's total assets was $94.68M at Sep 30, 2026. For fiscal 2025 it was $103.58M, down 12.8% from the year before. The highest annual figure on record is $166.51M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.58M | -12.8% |
| FY2024 | Dec 31, 2024 | $118.77M | -7.6% |
| FY2023 | Dec 31, 2023 | $128.59M | -15.5% |
| FY2022 | Dec 31, 2022 | $152.26M | -8.6% |
| FY2021 | Dec 31, 2021 | $166.51M | +164.7% |
| FY2020 | Dec 31, 2020 | $62.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $94.68M | -12.0% |
| Q2 FY2026 | Jun 30, 2026 | $95.88M | -13.2% |
| Q1 FY2026 | Mar 31, 2026 | $98.66M | -13.5% |
| Q4 FY2025 | Dec 31, 2025 | $103.58M | -12.8% |
| Q3 FY2025 | Sep 30, 2025 | $107.63M | -13.3% |
| Q2 FY2025 | Jun 30, 2025 | $110.49M | -4.2% |
| Q1 FY2025 | Mar 31, 2025 | $113.99M | -5.6% |
| Q4 FY2024 | Dec 31, 2024 | $118.77M | -7.6% |
| Q3 FY2024 | Sep 30, 2024 | $124.10M | -10.3% |
| Q2 FY2024 | Jun 30, 2024 | $115.35M | -13.0% |
| Q1 FY2024 | Mar 31, 2024 | $120.82M | -14.3% |
| Q4 FY2023 | Dec 31, 2023 | $128.59M | -15.5% |
| Q3 FY2023 | Sep 30, 2023 | $138.39M | -13.7% |
| Q2 FY2023 | Jun 30, 2023 | $132.55M | -27.2% |
| Q1 FY2023 | Mar 31, 2023 | $141.02M | -23.4% |
| Q4 FY2022 | Dec 31, 2022 | $152.26M | -8.6% |
| Q3 FY2022 | Sep 30, 2022 | $160.27M | -5.3% |
| Q2 FY2022 | Jun 30, 2022 | $182.20M | +5.6% |
| Q1 FY2022 | Mar 31, 2022 | $184.08M | +192.6% |
| Q4 FY2021 | Dec 31, 2021 | $166.51M | – |
| Q3 FY2021 | Sep 30, 2021 | $169.16M | – |
| Q2 FY2021 | Jun 30, 2021 | $172.57M | – |
| Q4 FY2020 | Dec 31, 2020 | $62.91M | – |
See a number that looks wrong?